Generation Bio Correlations
| GBIO Stock | USD 5.25 0.15 2.78% |
The current 90-days correlation between Generation Bio and Verrica Pharmaceuticals is -0.18 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Generation Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Generation Bio Co moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Generation Bio Correlation With Market
Weak diversification
The correlation between Generation Bio Co and DJI is 0.31 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Generation Bio Co and DJI in the same portfolio, assuming nothing else is changed.
Generation | Build AI portfolio with Generation Stock |
Moving together with Generation Stock
Moving against Generation Stock
| 0.55 | VCYT | Veracyte | PairCorr |
| 0.49 | DSGN | Design Therapeutics | PairCorr |
| 0.42 | CMB | Cambium Bio | PairCorr |
| 0.36 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.36 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.34 | JUMP | Leveljump Healthcare Corp | PairCorr |
| 0.57 | VTVT | vTv Therapeutics | PairCorr |
| 0.52 | VRDN | Viridian Therapeutics | PairCorr |
| 0.51 | ENTX | Entera Bio | PairCorr |
| 0.36 | EFTR | Effector Therapeutics | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Generation Stock performing well and Generation Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Generation Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| VRCA | 3.23 | (0.65) | 0.00 | (1.98) | 0.00 | 7.95 | 20.24 | |||
| MURA | 0.74 | 0.27 | 0.36 | (1.10) | 0.00 | 0.97 | 17.07 | |||
| JSPR | 3.06 | (0.68) | 0.00 | (0.46) | 0.00 | 6.01 | 24.97 | |||
| NXTC | 4.46 | 1.27 | 0.18 | 10.18 | 5.68 | 11.75 | 60.54 | |||
| EVAX | 7.18 | 1.50 | 0.15 | (1.14) | 7.81 | 25.24 | 69.70 | |||
| QTTB | 4.64 | 0.32 | 0.05 | 0.64 | 5.98 | 10.19 | 30.60 | |||
| BOLD | 1.96 | 0.02 | 0.01 | 0.06 | 2.29 | 5.26 | 13.44 | |||
| SABS | 4.13 | 0.99 | 0.20 | 0.54 | 3.93 | 11.71 | 31.47 | |||
| CELU | 4.15 | (1.01) | 0.00 | (9.60) | 0.00 | 7.11 | 54.53 | |||
| BTAI | 4.68 | (1.49) | 0.00 | 6.34 | 0.00 | 6.40 | 28.20 |
Generation Bio Corporate Management
| Caitlin MBA | Senior Development | Profile | |
| Robert Kotin | CoFounder Advisor | Profile | |
| Sara Besten | Chief Officer | Profile | |
| Tracy Zimmermann | Chief Officer | Profile | |
| Phillip Samayoa | Chief Officer | Profile | |
| Jasmin Tower | Chief Officer | Profile | |
| MBA MD | Chief Officer | Profile |